| http://www.w3.org/ns/prov#value | - Since the current therapeutic arsenal is of limited impact on HDL-c levels, in particular the most popular medication, such as statins, and since a percentage of patients (of concern) present low HDL-c dyslipidemia and/or hypertriglyceridemia, nonpharmacological measures (including regular physical exercise and low-fat and low-sugar diets) might deserve more attention, as well as new and more effe
|
